Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about HER2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | HER2 |
| Key Genes/Proteins | AKT, PI3K, EGFR Family, ERK |
| Related Diseases | Breast Cancer, Gastric Cancer, cancer |
| Related Pathways | oxidative stress response |
Knowledge base pages for this entity
graph TD
HER2["HER2"]
style HER2 fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
HER2 -->|"regulates"| Cell_Proliferation["Cell Proliferation"]
HER2 -->|"regulates"| Cell_Survival["Cell Survival"]
HER2 -->|"promotes"| cell_proliferation["cell proliferation"]
HER2 -->|"promotes"| cell_survival["cell survival"]
HER2 -.->|"biomarker for"| Breast_Cancer["Breast Cancer"]
HER2 -->|"activates"| AKT([AKT])
HER2 -->|"activates"| PI3K([PI3K])
HER2 -->|"regulates"| cell_differentiation["cell differentiation"]
HER2 -->|"target for"| cancer["cancer"]
n_5A["5A"] -.->|"inhibits"| HER2
trastuzumab{"trastuzumab"} -->|"target for"| HER2
pertuzumab{"pertuzumab"} -->|"target for"| HER2
EGFR([EGFR]) -->|"interacts"| HER2
PI3K -.->|"inhibits"| HER2
CANCER([CANCER]) -->|"target for"| HER2
CDK4([CDK4]) -->|"target for"| HER2
MTOR([MTOR]) -.->|"inhibits"| HER2
AND([AND]) -->|"target for"| HER2
AKT -.->|"inhibits"| HER2| Target | Relation | Type | Str |
|---|---|---|---|
| Breast Cancer | associated_with | disease | 0.98 |
| Gastric Cancer | associated_with | disease | 0.98 |
| Cell Proliferation | regulates | process | 0.95 |
| Cell Survival | regulates | process | 0.95 |
| cell proliferation | promotes | process | 0.95 |
| cell survival | promotes | process | 0.95 |
| AKT | activates | protein | 0.90 |
| PI3K | activates | protein | 0.90 |
| cell differentiation | regulates | process | 0.90 |
| cancer | therapeutic_target | disease | 0.90 |
| EGFR Family | interacts_with | protein | 0.88 |
| ERK | upstream_of | protein | 0.85 |
| oxidative stress response | participates_in | pathway | 0.80 |
| PI3K-AKT-mTOR signaling | participates_in | pathway | 0.70 |
| apoptosis pathway | participates_in | pathway | 0.70 |
| Ms | inhibits | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| Ms | causes | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Aging | causes | disease | 0.65 |
| Alzheimer | causes | disease | 0.65 |
| Tumor | causes | disease | 0.65 |
| Als | causes | disease | 0.65 |
| Cancer | biomarker_for | disease | 0.65 |
| Ms | biomarker_for | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| ALS | causes | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Aging | inhibits | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Akt | inhibits | pathway | 0.60 |
| Mtor | inhibits | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| trastuzumab | therapeutic_target | drug | 0.90 |
| pertuzumab | therapeutic_target | drug | 0.90 |
| EGFR | interacts_with | gene | 0.80 |
| PI3K | inhibits | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| CDK4 | therapeutic_target | gene | 0.60 |
| MTOR | inhibits | gene | 0.60 |
| AND | therapeutic_target | gene | 0.60 |
| AKT | inhibits | gene | 0.60 |
| EGFR | therapeutic_target | gene | 0.60 |
| OVERVIEW | therapeutic_target | gene | 0.60 |
| PI3K | therapeutic_target | gene | 0.60 |
| CANCER | expressed_in | gene | 0.60 |
| MTOR | therapeutic_target | gene | 0.60 |
| AND | expressed_in | gene | 0.60 |
| AKT | therapeutic_target | gene | 0.60 |
| ALZHEIMER | causes | gene | 0.60 |
| CANCER | associated_with | gene | 0.60 |
| ALZHEIMER'S DISEASE | causes | gene | 0.60 |
| AXL | causes | gene | 0.60 |
| GAS6 | causes | gene | 0.60 |
| ASTROCYTES | causes | gene | 0.60 |
| DISEASE-ASSOCIATED MICROGLIA | causes | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| MICROGLIA | causes | gene | 0.60 |
| CANCER | biomarker_for | gene | 0.60 |
| RAS | expressed_in | gene | 0.60 |
| DNA | activates | gene | 0.60 |
| ERBB2 | associated_with | gene | 0.60 |
| AND | biomarker_for | gene | 0.60 |
| PIK3CA | activates | gene | 0.60 |
| BAD | inhibits | gene | 0.60 |
| ERBB2 | inhibits | gene | 0.60 |
| MITOPHAGY | associated_with | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| PER | associated_with | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| CD8 | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| CGAS | activates | gene | 0.60 |
| PD-L1 | activates | gene | 0.60 |
| AKT | associated_with | gene | 0.60 |
| AMYLOID | inhibits | gene | 0.60 |
| SOD1 | inhibits | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| ERK | inhibits | gene | 0.60 |
| C-JUN | inhibits | gene | 0.60 |
| MEK | inhibits | gene | 0.60 |
| CANCER | inhibits | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||